Feed Preview

Fast Growing

Multiple Sclerosis

Multiple Sclerosis diagram by Designua, Shutterstock
Designua, Shutterstock

Multiple Sclerosis is a demyelinating autoimmune disease of the CNS, resulting in symptoms including optic neuritis and motor weakness. Discover the latest research on Multiple Sclerosis here.

Top 20 most recent papers
Lancet Neurology

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

Lancet NeurologyJanuary 26, 2020
Jeremy ChatawayMS-SMART Investigators
76
1
Clinical Journal of the American Society of Nephrology : CJASN

Reproducibility of Deceased Donor Kidney Procurement Biopsies

Clinical Journal of the American Society of Nephrology : CJASNJanuary 25, 2020
S Ali HusainSumit Mohan
4
Neuroepidemiology

Feasibility of Using a Nationally Representative Telephone Survey to Monitor Multiple Sclerosis Prevalence in the United States

NeuroepidemiologyJanuary 29, 2020
Stephen L BukaNicholas LaRocca
Lancet Neurology

Feast or famine in multiple sclerosis therapeutics

Lancet NeurologyJanuary 26, 2020
Robert J Fox
23
Journal of Neurology, Neurosurgery, and Psychiatry

Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis

Journal of Neurology, Neurosurgery, and PsychiatryJanuary 25, 2020
Luca ProsperiniClaudio Gasperini
16
Bioconjugate Chemistry

Biocompatible Chemotherapy for Leukemia by Acid-Cleavable, PEGylated FTY720

Bioconjugate ChemistryJanuary 28, 2020
Jessica A KempYoung Jik Kwon
1
Advanced Drug Delivery Reviews

Fatty acid metabolism in the progression and resolution of CNS disorders

Advanced Drug Delivery ReviewsJanuary 29, 2020
Jeroen F J BogieJerome J A Hendriks
Frontiers in Neuroendocrinology

Pregnancy, Postpartum and Parity: Resilience and Vulnerability in Brain Health and Disease

Frontiers in NeuroendocrinologyJanuary 29, 2020
Nicholas Deems, Benedetta Leuner
Multiple Sclerosis and Related Disorders

Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients

Multiple Sclerosis and Related DisordersJanuary 27, 2020
Floriane CalocerGilles Defer
17
bioRxiv

Summary-data-based mendelian randomisation reveals druggable targets for multiple sclerosis

bioRxivJanuary 25, 2020
Benjamin Meir JacobsRuth Dobson
Journal of Neuroinflammation

High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy

Journal of NeuroinflammationJanuary 26, 2020
Antonio Heras-GarvinNadia Stefanova
5
International Urology and Nephrology

Worsening disability status in multiple sclerosis predicts urologic complications

International Urology and NephrologyJanuary 27, 2020
Alejandro AbelloAnurag K Das
4
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Italian translation and psychometric validation of the Manual Ability Measure-36 (MAM-36) and its correlation with an objective measure of upper limb function in patients with multiple sclerosis

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyJanuary 25, 2020
Claudio SolaroDavide Marengo
3
Multiple Sclerosis and Related Disorders

Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case series

Multiple Sclerosis and Related DisordersJanuary 28, 2020
E SignorielloG Lus
4
Multiple Sclerosis and Related Disorders

Maternal micro-chimeric cells in the multiple sclerosis brain

Multiple Sclerosis and Related DisordersJanuary 28, 2020
Heidi SnethenNeil J Scolding
2
The Journal of Steroid Biochemistry and Molecular Biology

Canadian Recommendations for Vitamin D Intake for Persons Affected by Multiple Sclerosis

The Journal of Steroid Biochemistry and Molecular BiologyJanuary 26, 2020
Stephanie A Atkinson, James C Fleet
3
Multiple Sclerosis and Related Disorders

Evaluation of ethnicity as a predictor of diagnostic phenotype and prognosis in neuromyelitis optica spectrum disorder in Toronto, Canada

Multiple Sclerosis and Related DisordersJanuary 27, 2020
Karly StratosDalia Rotstein
Journal of Neuroinflammation

Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy

Journal of NeuroinflammationJanuary 29, 2020
Bereketeab HaileselassieDaria Mochly-Rosen
Journal of Clinical Medicine

Role of Arginase 2 in Murine Retinopathy Associated with Western Diet-Induced Obesity

Journal of Clinical MedicineJanuary 26, 2020
Reem T AtawiaR William Caldwell
1
Neurología : publicación oficial de la Sociedad Española de Neurología

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

Neurología : publicación oficial de la Sociedad Española de NeurologíaJanuary 29, 2020
J E Meca-LallanaX Montalbán Gairin

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/multiple-sclerosis/ea8d70cb-fbc6-4170-baee-bf863c65dc90